Migraine Without Aura

• FDA approval · 2015-07-07
  FDA Approved: ALMOTRIPTAN MALATE — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva's almotriptan malate as an original ANDA, providing a generic option for the acute treatment of migraines.

• FDA approval · 2012-04-30
  FDA Approved: NARATRIPTAN — Original Application (Bionpharma Inc.)

  FDA approves Bionpharma's Naratriptan as a generic treatment for acute migraine (with or without aura).